$礼来(LLY)$ 这么看好啊。。。

GlobalData predicts sales of Novo's Ozempic will increase by 23% in 2023, reaching $12.5 billion. For their part, analysts with ODDO BHF have said they expect Novo's Wegovy to pull down more than $4 billion this year.

Meanwhile, Mounjaro’s sales are expected to reach $3 billion this year. Analysts at SVB Securities have projected sales from the drug could reach a whopping $26.4 billion by 2030.